May. 19 at 4:15 PM
$NAGE This stock should be
$15 per share. Let me tell you why it's not. Their marketing is headed in the wrong direction, and I'll give you three examples. First, injections. When GLP1's came out, you had to take the needle. Now they have a pill, which is what people wanted, (the right direction). Niagen has a pill, but they went to injections,(the wrong direction). Second example: Cruise ships. People go on cruises to eat and drink and have a good time. They don't want to go to a clinic fo an IV, and spend the rest of their cruise possibly having side effects. Third example: When older folks with money want NR, they want the best deal they can get on NR. If they want to add additional supplements, they can get them at Walgreens. In my opinion, they should have only one size dose of only NR, in one size bottle. Their advertising should explain clearly what the product does, and for older folks they should be made to understand this should be as common as vitamin D or C. Just Sayin...
